Data / Form D filings / Topos Bio, Inc.
Topos Bio, Inc.: Form D filing
Topos Bio, Inc., a company in San Francisco, CA, filed a Form D with the SEC in 2025. The latest, on January 7, 2025, reports $9 million sold of a $10.5 million offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1517 N. POINT STREET #445-A, San Francisco, CA, 94123
- Phone
- (510) 806-7955
- Industry
- Other
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2024
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2050962
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 7, 2025 | New notice | $10,499,989 | $8,999,995 | $1,499,994 | 2 | Dec 23, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Amir Khosrowshahi | Executive Officer, Director, Promoter | |
| Ellen Chisa | Director | |
| Ryan Zarcone | Executive Officer, Director, Promoter |
Other companies in California that filed recently
- Crosscut SPV Frontier LP - Series 2 $23.4 million · Oct 30, 2026
- Series 23-1, a series of StartEngine Private Funds LLC $314,025 · Oct 30, 2026
- Omnissa Holdco LLC offering · Oct 30, 2026
- Angle Health, Inc. $591.5 million · Oct 29, 2026
- Agilis Medical, Inc. $4 million · Oct 28, 2026
- Bridgeview Innovations, Inc. $10.3 million · Oct 28, 2026
Every Form D from the week of Jan 6, 2025 · All recent filings in California · All recent Other filings
Read from SEC EDGAR. Amount sold is what Topos Bio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.